S Y Park1, D K Kang, T H Kim. 1. Department of Radiology, Ajou University School of Medicine, Suwon, Republic of Korea.
Abstract
OBJECTIVE: The purpose of our study was to evaluate whether strong background parenchymal enhancement (BPE) would be a significant independent factor associated with positive resection margin in patients treated initially with breast-conserving surgery (BCS). METHODS: Retrospective evaluation of breast MRI examinations of 314 patients with breast cancer was carried out. Breast cancer was histologically confirmed in all patients who underwent BCS from January 2008 to December 2010. BPE was dichotomized into weak (minimal or mild) and strong (moderate or marked) enhancement for statistical analysis. Histopathological features of attained specimens were evaluated by an experienced pathologist and were also dichotomized for statistical analysis. RESULTS: On univariate analysis, positive extensive intraductal component (p < 0.001), strong BPE (p = 0.001) and human epidermal growth factor receptor 2 (HER2) positivity (p = 0.08) had significant association with positive surgical margin. Tumour size, axillary lymph node metastasis, nuclear grade, histological grade, lymphovascular invasion, oestrogen receptor and progesterone receptor did not show significant correlation with positive surgical margin. On multivariate analysis, the significant independent predictors were extensive intraductal component [odds ratio, 5.68; 95% confidence interval (CI), 2.72-11.82] and strong BPE (odds ratio, 2.39; 95% CI, 1.20-4.78). CONCLUSION: Strong BPE is a significant independent factor for positive resection margin along with positive extensive intraductal component, and performing MRI during the period of lower parenchymal enhancement is needed in patients with strong BPE. ADVANCES IN KNOWLEDGE: As far as we know, this is the first study to reveal that BPE is a significant independent factor associated with positive resection margin.
OBJECTIVE: The purpose of our study was to evaluate whether strong background parenchymal enhancement (BPE) would be a significant independent factor associated with positive resection margin in patients treated initially with breast-conserving surgery (BCS). METHODS: Retrospective evaluation of breast MRI examinations of 314 patients with breast cancer was carried out. Breast cancer was histologically confirmed in all patients who underwent BCS from January 2008 to December 2010. BPE was dichotomized into weak (minimal or mild) and strong (moderate or marked) enhancement for statistical analysis. Histopathological features of attained specimens were evaluated by an experienced pathologist and were also dichotomized for statistical analysis. RESULTS: On univariate analysis, positive extensive intraductal component (p < 0.001), strong BPE (p = 0.001) and humanepidermal growth factor receptor 2 (HER2) positivity (p = 0.08) had significant association with positive surgical margin. Tumour size, axillary lymph node metastasis, nuclear grade, histological grade, lymphovascular invasion, oestrogen receptor and progesterone receptor did not show significant correlation with positive surgical margin. On multivariate analysis, the significant independent predictors were extensive intraductal component [odds ratio, 5.68; 95% confidence interval (CI), 2.72-11.82] and strong BPE (odds ratio, 2.39; 95% CI, 1.20-4.78). CONCLUSION: Strong BPE is a significant independent factor for positive resection margin along with positive extensive intraductal component, and performing MRI during the period of lower parenchymal enhancement is needed in patients with strong BPE. ADVANCES IN KNOWLEDGE: As far as we know, this is the first study to reveal that BPE is a significant independent factor associated with positive resection margin.
Authors: K E Pengel; C E Loo; H J Teertstra; S H Muller; J Wesseling; J L Peterse; H Bartelink; E J Rutgers; K G A Gilhuijs Journal: Breast Cancer Res Treat Date: 2008-09-21 Impact factor: 4.872
Authors: Neslihan Cabioglu; Kelly K Hunt; Aysegul A Sahin; Henry M Kuerer; Gildy V Babiera; S Eva Singletary; Gary J Whitman; Merrick I Ross; Frederick C Ames; Barry W Feig; Thomas A Buchholz; Funda Meric-Bernstam Journal: Ann Surg Oncol Date: 2007-01-28 Impact factor: 5.344
Authors: M R Bani; M P Lux; K Heusinger; E Wenkel; A Magener; R Schulz-Wendtland; M W Beckmann; P A Fasching Journal: Eur J Surg Oncol Date: 2008-06-09 Impact factor: 4.424
Authors: Emil D Kurniawan; Matthew H Wong; Imogen Windle; Allison Rose; Arlene Mou; Malcolm Buchanan; John P Collins; Julie A Miller; Russell L Gruen; G Bruce Mann Journal: Ann Surg Oncol Date: 2008-07-10 Impact factor: 5.344
Authors: Geraldine J Liao; Leah C Henze Bancroft; Roberta M Strigel; Rhea D Chitalia; Despina Kontos; Linda Moy; Savannah C Partridge; Habib Rahbar Journal: J Magn Reson Imaging Date: 2019-04-19 Impact factor: 4.813
Authors: H Preibsch; L Wanner; S D Bahrs; B M Wietek; K C Siegmann-Luz; E Oberlecher; M Hahn; A Staebler; K Nikolaou; B Wiesinger Journal: Eur Radiol Date: 2015-09-17 Impact factor: 5.315
Authors: Suzan Vreemann; Albert Gubern-Mérida; Cristina Borelli; Peter Bult; Nico Karssemeijer; Ritse M Mann Journal: PLoS One Date: 2018-01-19 Impact factor: 3.240
Authors: Young-Sil An; Yongsik Jung; Ji Young Kim; Sehwan Han; Doo Kyoung Kang; Seon Young Park; Tae Hee Kim Journal: J Breast Cancer Date: 2017-12-19 Impact factor: 3.588
Authors: Jung-Hyun Kang; Ji Hyun Youk; Jeong-Ah Kim; Hye Mi Gweon; Na Lae Eun; Kyung Hee Ko; Eun Ju Son Journal: Korean J Radiol Date: 2018-08-06 Impact factor: 3.500